1342
H. Zhang et al.
LETTER
(5) For selected examples of aza-analogues of ganciclovir/
penciclovir or acyclovir, see: (a) Koszytkowska-Stawińska,
M.; Sas, W. Tetrahedron Lett. 2004, 45, 5437.
Goddertz, D. P.; Beceno, C.; Raabe, G. Adv. Synth. Catal.
2010, 352, 2863. (f) Gonzalez, P. B.; Lopez, R.; Palomo, C.
J. Org. Chem. 2010, 75, 3920. (g) Zhang, H.; Chen, M. G.;
Lian, C. X.; Yuan, W. C.; Zhang, X. M. Synlett 2010, 1415.
(h) Zhao, D. P.; Yang, D. X.; Wang, Y. J.; Wang, Y.; Wang,
L. Q.; Mao, L. J.; Wang, R. Chem. Sci. 2011, 2, 1918.
(i) Mita, T.; Higuchi, Y.; Sato, Y. Org. Lett. 2011, 13, 2354.
(j) Dou, X. Y.; Shuai, Q.; He, L. N.; Li, C. J. Inorg. Chim.
Acta 2011, 369, 284. (k) Jin, Y.; Song, B. A.; Li, X. Y.;
Bhadury, P. S.; Wang, Z. C.; Yang, S. Chem. Cent. J. 2011,
5, 21.
(b) Koszytkowska-Stawińska, M.; Sas, W.; De Clercq, E.
Tetrahedron 2006, 62, 10325. (c) Koszytkowska-Stawińska,
M.; Kaleta, K.; Sas, W. Nucleosides, Nucleotides Nucleic
Acids 2007, 26, 51. (d) Koszytkowska-Stawińska, M.;
Kołaczkowska, E.; Adamkiewicz, E.; De Clercq, E.
Tetrahedron 2007, 63, 10587. (e) Koszytkowska-Stawińska,
M. Nucleosides, Nucleotides Nucleic Acids 2010, 29, 768.
(f) Bergmeier, S. C.; Fundy, S. L.; Drach, J. C. Nucleosides,
Nucleotides Nucleic Acids 1999, 18, 227.
(10) General Procedure for Addition of Purines 1 with
α-Amido Sulfones 2:
(6) For selected examples of other acyclic azanucleosides, see:
(a) Gawin, R.; De Clercq, E.; Naesens, L.; Koszytkowska-
Stawińska, M. Bioorg. Med. Chem. 2008, 16, 8379.
(b) Koszytkowska-Stawińska, M.; De Clercq, E.; Balzarini,
J. Bioorg. Med. Chem. 2009, 17, 3756. (c) Zhou, D.; Lagoja,
I. M.; Aerschot, V.; Herdewijn, P. Collect. Czech. Chem.
Commun. 2006, 71, 15. (d) Guo, H. M.; Wu, Y. Y.; Niu, H.
Y.; Wang, D. C.; Qu, G. R. J. Org. Chem. 2010, 75, 3863.
(7) Zhong, M. H.; Robins, M. J. J. Org. Chem. 2006, 71, 8901.
(8) (a) Petrini, M. Chem. Rev. 2005, 105, 3949. (b) Petrini, M.;
Torregiani, E. Synthesis 2007, 159. (c) Yang, J. W.; Pan, S.
C.; List, B. Org. Synth. 2009, 86, 11. (d) Alba, A. N. R.;
Companyo, X.; Rios, R. Chem. Soc. Rev. 2010, 39, 2018.
(e) Yin, B. L.; Zhang, Y. X.; Xu, L. W. Synthesis 2010,
3583.
N-Boc α-amido sulfone (0.2 mmol, 1.0 equiv), Na2CO3 (0.3
mmol, 1.5 equiv), and H2O (2 mL) were put in a 10-mL glass
vial equipped with a small magnetic stirring bar. To the
solution was added purine derivative (0.24 mmol, 1.2 equiv).
After stirring for the stipulated time at r.t., the mixture was
diluted with H2O (5 mL) and extracted with EtOAc (3 × 25
mL, for 3aa–3ak, 3ca and 3cj) or CHCl3 (3 × 25 mL, for
3ba, 3da, 3ea, 3fa and 3ga). The organic layers were
combined, dried over anhyd Na2SO4 and concentrated under
reduced pressure. The residue was subjected to silica gel
flash chromatography (EtOAc–hexanes, 1:5) to give the
pure product.
(11) tert-Butyl Cyclohexyl (2,6-Dichloro-9H-purin-9-
yl)methylcarbamate (3aa):
(9) For some recent examples, see: (a) Sohtome, Y.; Tanaka, S.;
Takada, K.; Yamaguchi, T.; Nagasawa, K. Angew. Chem.
Int. Ed. 2010, 49, 9254. (b) Zhang, H. L.; Syed, S.; Barbas,
C. F. Org. Lett. 2010, 12, 708. (c) Galzerano, P.; Agostino,
D.; Bencivenni, G.; Sambri, L.; Bartoli, G.; Melchiorre, P.
Chem.–Eur. J. 2010, 16, 6069. (d) Abermil, N.; Masson, G.;
Zhu, J. P. Adv. Synth. Catal. 2010, 352, 656. (e) Enders, D.;
yield: 97%; white solid; mp 182.7–183.3 °C. 1H NMR (300
MHz, CDCl3): δ = 8.15 (s, 1 H), 8.83 (br, 1 H), 5.63–5.69 (m,
1 H), 2.33 (br, 1 H), 1.65–2.02 (m, 4 H), 1.37 (s, 9 H), 0.83–
1.36 (m, 6 H).13C NMR (75 MHz, CDCl3): δ = 154.5, 152.6,
152.4, 151.8, 145.7, 131.3, 81.3, 69.4, 40.1, 29.4, 29.1, 28.1,
25.7, 25.2, 25.1. HRMS (ESI): m/z [M + Na]+ calcd for
C17H23Cl2N5NaO2: 422.1121; found: 422.1138.
Synlett 2012, 23, 1339–1342
© Georg Thieme Verlag Stuttgart · New York